As of 2025-07-22, the Relative Valuation of Cell MedX Corp (CMXC) is (1.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.45 USD, the upside of Cell MedX Corp based on Relative Valuation is -378.1%.
The range of the Relative Valuation is (1.00) - (1.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 19.0x | 12.1x |
| Forward P/E multiples | 9.7x - 18.2x | 12.1x |
| Fair Price | (1.00) - (1.87) | (1.25) |
| Upside | -322.5% - -517.8% | -378.1% |
| Date | P/E |